Combining Daratumumab with VRd Improves Outcomes in Patients with Transplant-Ineligible or Transplant-Deferred Newly Diagnosed Multiple Myeloma By Ogkologos - March 3, 2025 351 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the CEPHEUS study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer ESMO Calls for Robust EU Taxation of Tobacco Products, Aiming to Prevent Cancers Attributable to Tobacco Use EMA Recommends Granting a Marketing Authorisation for Biosimilar Pegfilgrastim MOST POPULAR GreaterGood’s Inaugural Breast Cancer Research Professor Is Changing the Face of... October 1, 2020 EMA Recommends Extension of Indications for Durvalumab in the Management of... October 25, 2023 Opinion: ‘Let’s not be short-sighted – the UK’s medical research charities... September 24, 2020 Droplet Transmission vs. Airborne… What’s the difference? August 10, 2020 Load more HOT NEWS EMA Recommends Granting Marketing Authorisation for Efbemalenograstim Alfa How Some Brain Tumors Hijack the Mind to Grow 10 Ways to Brave Cancer Treatment: Tips from a Survivor Shelter Puppies Got A Private Tour Of The Georgia Aquarium
